AGO2 and melanoma: Analysis of melanoma patient data from “The Cancer Genome Atlas (TGCA) SpliceSeq Database” (https://bioinformatics.mdanderson.org/TCGASpliceSeq/singlegene.jsp, [18]) also revealed that in some patients (11%) a splicing event occurs in which exon2 is skipped in the AGO2 CDS.